Sensitivity of Mitochondrial Transcription and Resistance of RNA Polymerase II Dependent Nuclear Transcription to Antiviral Ribonucleosides
暂无分享,去创建一个
J. Arnold | C. Cameron | A. Gnatt | W. Zhong | E. Smidansky | M. Kashlev | B. Peterson | M. Kireeva | Suresh D. Sharma | A. Ray | Joy Y. Feng | Yeojin Park | D. Babusis | Jason K. Perry | Yili Xu | Ya-Wen Tian | A. Cho | Jennifer E. Vela | Ona Barauskus
[1] P. Cramer,et al. Structure of human mitochondrial RNA polymerase , 2011, Nature.
[2] C. Rice,et al. Turning hepatitis C into a real virus. , 2011, Annual review of microbiology.
[3] W. Delaney,et al. Screening of Hepatitis C Virus Inhibitors Using Genotype 1a HCV Replicon Cell Lines , 2011, Current protocols in microbiology.
[4] B. Coulombe,et al. Interaction of RNA Polymerase II Fork Loop 2 with Downstream Non-template DNA Regulates Transcription Elongation* , 2011, The Journal of Biological Chemistry.
[5] J. Arnold,et al. Human mitochondrial RNA polymerase: evaluation of the single-nucleotide-addition cycle on synthetic RNA/DNA scaffolds. , 2011, Biochemistry.
[6] L. Wheeler,et al. Nucleoside Triphosphate Pool Asymmetry in Mammalian Mitochondria* , 2011, The Journal of Biological Chemistry.
[7] T. Robak. New nucleoside analogs for patients with hematological malignancies , 2011, Expert opinion on investigational drugs.
[8] D. Hazuda,et al. Sustained Viral Response in a Hepatitis C Virus-Infected Chimpanzee via a Combination of Direct-Acting Antiviral Agents , 2010, Antimicrobial Agents and Chemotherapy.
[9] M. Otto,et al. Discovery of a β-d-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus. , 2010, Journal of medicinal chemistry.
[10] K. Anderson. A transient kinetic approach to investigate nucleoside inhibitors of mitochondrial DNA polymerase gamma. , 2010, Methods.
[11] S. Zeuzem,et al. Review article: specifically targeted anti‐viral therapy for hepatitis C – a new era in therapy , 2010, Alimentary pharmacology & therapeutics.
[12] Huiling Yang,et al. Novel Hepatitis C Virus Reporter Replicon Cell Lines Enable Efficient Antiviral Screening against Genotype 1a , 2010, Antimicrobial Agents and Chemotherapy.
[13] M. Otto,et al. PSI-7851, a Pronucleotide of β-d-2′-Deoxy-2′-Fluoro-2′-C-Methyluridine Monophosphate, Is a Potent and Pan-Genotype Inhibitor of Hepatitis C Virus Replication , 2010, Antimicrobial Agents and Chemotherapy.
[14] J. Arnold,et al. Identification of Multiple Rate-limiting Steps during the Human Mitochondrial Transcription Cycle in Vitro* , 2010, The Journal of Biological Chemistry.
[15] I. Shih,et al. Comparison of HCV NS3 protease and NS5B polymerase inhibitor activity in 1a, 1b and 2a replicons and 2a infectious virus. , 2009, Antiviral research.
[16] M. Kashlev,et al. Millisecond phase kinetic analysis of elongation catalyzed by human, yeast, and Escherichia coli RNA polymerase. , 2009, Methods.
[17] William A. Lee,et al. Nucleotide analogue prodrug tenofovir disoproxil enhances lymphoid cell loading following oral administration in monkeys. , 2009, Molecular pharmaceutics.
[18] N. Brown. Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nucleoside analogues. , 2009, Expert opinion on investigational drugs.
[19] D. Hazuda,et al. Robust Antiviral Efficacy upon Administration of a Nucleoside Analog to Hepatitis C Virus-Infected Chimpanzees , 2008, Antimicrobial Agents and Chemotherapy.
[20] Klaus Klumpp,et al. Characterization of the Metabolic Activation of Hepatitis C Virus Nucleoside Inhibitor β-d-2′-Deoxy-2′-fluoro-2′-C-methylcytidine (PSI-6130) and Identification of a Novel Active 5′-Triphosphate Species* , 2007, Journal of Biological Chemistry.
[21] Blake R. Peterson,et al. Lethal Mutagenesis of Poliovirus Mediated by a Mutagenic Pyrimidine Analogue , 2007, Journal of Virology.
[22] C. Gustafsson,et al. DNA replication and transcription in mammalian mitochondria. , 2007, Annual review of biochemistry.
[23] Yvonne Will,et al. Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[24] Yvonne Will,et al. Strategies to reduce late-stage drug attrition due to mitochondrial toxicity , 2007, Expert review of molecular diagnostics.
[25] T. Robak,et al. Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity. , 2006, Current medicinal chemistry.
[26] T. Robak,et al. Pharmacological and clinical studies on purine nucleoside analogs--new anticancer agents. , 2006, Mini reviews in medicinal chemistry.
[27] R. Devos,et al. The Novel Nucleoside Analog R1479 (4′-Azidocytidine) Is a Potent Inhibitor of NS5B-dependent RNA Synthesis and Hepatitis C Virus Replication in Cell Culture* , 2006, Journal of Biological Chemistry.
[28] D. Wallace. A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine , 2005, Annual review of genetics.
[29] S. Dimauro,et al. Mitochondrial DNA copy number threshold in mtDNA depletion myopathy , 2005, Neurology.
[30] J. Tomassini,et al. Inhibitory Effect of 2′-Substituted Nucleosides on Hepatitis C Virus Replication Correlates with Metabolic Properties in Replicon Cells , 2005, Antimicrobial Agents and Chemotherapy.
[31] Giovanni Migliaccio,et al. A 7-Deaza-Adenosine Analog Is a Potent and Selective Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic Properties , 2004, Antimicrobial Agents and Chemotherapy.
[32] P. D. Cook,et al. Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication. , 2004, Journal of medicinal chemistry.
[33] A. Ray,et al. Role of Purine Nucleoside Phosphorylase in Interactions between 2′,3′-Dideoxyinosine and Allopurinol, Ganciclovir, or Tenofovir , 2004, Antimicrobial Agents and Chemotherapy.
[34] Quanlai Song,et al. Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase. , 2004, Journal of medicinal chemistry.
[35] Yurong Lai,et al. Mitochondrial Expression of the Human Equilibrative Nucleoside Transporter 1 (hENT1) Results in Enhanced Mitochondrial Toxicity of Antiviral Drugs* , 2004, Journal of Biological Chemistry.
[36] M. Otto,et al. Inhibition of the Subgenomic Hepatitis C Virus Replicon in Huh-7 Cells by 2′-Deoxy-2′-Fluorocytidine , 2004, Antimicrobial Agents and Chemotherapy.
[37] Kenneth A. Johnson,et al. Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase. , 2003, Biochemistry.
[38] B. Day,et al. Mitochondrial toxicity of nrti antiviral drugs: an integrated cellular perspective , 2003, Nature Reviews Drug Discovery.
[39] Lawrence C Kuo,et al. Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs* , 2003, The Journal of Biological Chemistry.
[40] C. Kane,et al. Promoting elongation with transcript cleavage stimulatory factors. , 2002, Biochimica et biophysica acta.
[41] Alex J White,et al. Mitochondrial toxicity and HIV therapy , 2001, Sexually transmitted infections.
[42] Z. Jiang,et al. Characterization of a dCTP Transport Activity Reconstituted from Human Mitochondria* , 1999, The Journal of Biological Chemistry.
[43] S. Orlicky,et al. Transcription Elongation through DNA Arrest Sites , 1997, The Journal of Biological Chemistry.
[44] H. Conjeevaram,et al. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. , 1995, The New England journal of medicine.
[45] R. Kozłowski,et al. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. , 1993, Journal of immunological methods.
[46] O. Yoo,et al. Cloning, expression and characterization of the human transcription elongation factor, TFIIS. , 1991, Nucleic acids research.
[47] Luis Carrasco,et al. Molecular bases for the action and selectivity of nucleoside antibiotics , 1984, Medicinal research reviews.
[48] A. Bloch. Chemistry, biology, and clinical uses of nucleoside analogs , 1975 .
[49] CHARLES A. Haile. Chloramphenicol toxicity. , 1969, Lancet.
[50] K. Watanabe,et al. Nucleoside antibiotics. , 1966, Progress in nucleic acid research and molecular biology.